Lipids and carbohydrates in nutritional concepts for tumor patients;Fette und Kohlenhydrate in Ernährungskonzepten für Tumorpatienten

Aktuelle Ernahrungsmedizin

Volumn 36, Issue 5, 2011, Pages 286-298

  Holm, E ^a   Kammerer U ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

carbohydrates; lipids; metabolism; nutritional concepts; tumor patients

Indexed keywords

CARBOHYDRATE; FATTY ACID; LIPID;

ARTICLE; CANCER INHIBITION; CANCER PATIENT; CANCER THERAPY; CARCINOMA; CLEARANCE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HUMAN; INSULIN RESISTANCE; KETOGENIC DIET; LIPID DIET; LIPID OXIDATION; MALNUTRITION; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE PHOSPHORYLATION; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPLANCHNIC BLOOD FLOW; TUMOR;

EID: 80053568459     PISSN: 03410501     EISSN: 14389916     Source Type: Journal    
DOI: 10.1055/s-0031-1276918     Document Type: Article

References (105)

1. Rohdenburg G L., Bernhard A, Krehbiel A. Sugar tolerance in cancer. J Am Med Ass 1919 72 1528-1534
2. Marks P A., Bishop J S. The glucose metabolism of patients with malignant disease and normal subjects as studied by means of an intravenous glucose tolerance test. J Clin Invest 1957 36 254-264
3. Rothkopf M. Fuel utilization in neoplastic disease: Implications for the use of nutritional support in cancer patients. Nutrition 1990 6 14S-16S (Pubitemid 20272724)
4. Grosvenor M, Bulcavage L, Chlebowski R T. Symptoms potentially influencing weight loss in a cancer population. Cancer 1989 63 330-334
5. Holm E, Staedt U, Leweling H et al. Metabolism and artificial nutrition of patients with malignancy. SA J Clin Nutr 1993 6 10-21
6. Heymsfield S A., McManus C B. Tissue components of weight loss in cancer patients. A new method of study and preliminary observations. Cancer 1985 55 238-249 (Pubitemid 15155448)
7. Fearon K C., Preston T. Body composition in cancer cachexia. Infusionstherapie 1990 17 63-66 (Pubitemid 20199173)
8. Evans W K., Nixon D W., Daly J M. et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 1987 5 113-124 (Pubitemid 17007865)
9. Bozzetti F, Gavazzi C, Mariani L et al. Artificial nutrition in cancer patients: Which route, what composition? World J Surg 1999 23 577-583 (Pubitemid 29215630)
10. Makino T, Noguchi Y, Yoshikawa T. Circulating interleukin 6 concentrations and insulin resistance in patients with cancer. Br J Surg 1998 85 1658-1662 (Pubitemid 28548342)
11. Toso S, Piccoli A, Gusella M et al. Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition 2000 16 120-124 (Pubitemid 30103713)
12. Holm E. Stoffwechsel und Ernährung bei Tumorkrankheiten. Stuttgart, New York Thieme 2007
13. Cersosimo E, Pisters P WT, Pesola G et al. The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia. Surgery 1991 109 459-467
14. Permert J, Adrian T E., Jacobsson P et al. Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 1993 165 61-66
15. Yoshikawa T, Noguchi Y, Matsumoto A. Effects of tumor removal and body weight loss on insulin resistance in patients with cancer. Surgery 1994 116 62-66 (Pubitemid 24226915)
16. Marat D, Noguchi Y, Yoshikawa T et al. Insulin resistance and tissue glycogen content in the tumor-bearing state. Hepato-Gastroenterology 1999 46 3159-3165
17. McCall J L., Tuckey J A., Parry B R. Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer. Br J Surg 1992 79 1361-1363 (Pubitemid 23008406)
18. Norton J A., Maher M, Wesley R et al. Glucose intolerance in sarcoma patients. Cancer 1984 54 3022-3027 (Pubitemid 15184088)
19. Tayek J A., Manglik S, Abemayor E. Insulin secretion, glucose production, and insulin sensitivity in underweight and normal-weight volunteers, and in underweight and normal-weight cancer patients: A clinical research center study. Metabolism 1997 46 140-145 (Pubitemid 27078756)
20. Gambardella A, Tortoriello R, Tagliamonte M R. et al. Metabolic changes in elderly cancer patients after glucose ingestion. The role of tumor necrosis factor-. Cancer 1997 79 177-184 (Pubitemid 26425524)
21. Wolfe R R. Metabolic interactions between glucose and fatty acids in humans. Am J Clin Nutr 1998 67 519S-526S (Pubitemid 28117234)
22. Körber J, Pricelius S, Heidrich M et al. Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight. Eur J Clin Nutr 1999 53 740-745 (Pubitemid 29424005)
23. Hansell D T., Davies J WL, Burns H JG et al. The oxidation of body fuel stores in cancer patients. Ann Surg 1986 204 637-642 (Pubitemid 17207291)
24. Richards E W., Long C L., Nelson K M. et al. Glucose metabolism in advanced lung cancer patients. Nutrition 1992 8 245-251
25. Selberg O, Weimann A, Meyer H J. et al. Lipolyse und Lipidoxidation bei gewichtsstabilen Patienten mit malignen Tumoren des Verdauungstraktes. Infusionstherapie 1991 18 80-84
26. Zuijdgeest-van Leeuwen S D., van den Berg J WO, Darcos Wattimena J L. et al. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism 2000 49 931-936 (Pubitemid 30483448)
27. Frayn K N. Metabolic Regulation. A Human Perspective. 3rd ed. Oxford Wiley-Blackwell 2010
28. Shaw J HF, Wolfe F F. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding. Ann Surg 1987 205 368-376 (Pubitemid 17059427)
29. Jeevanandam M, Horowitz G D., Lowry S F. et al. Cancer cachexia and the rate of whole body lipolysis in man. Metabolism 1986 35 304-310 (Pubitemid 16079520)
30. Beck S A., Mulligan H D., Tisdale M J. Lipolytic factors associated with murine and human cancer cachexia. J Natl Cancer Inst 1990 82 1922-1926
31. Barber M D., McMillan D C., Preston T et al. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci 2000 98 398-399
32. Stütz O. Metabolische Untersuchungen an Karzinompatienten: Substrataustausch der peripheren Gewebe und Hypernephrom-tragender Nieren. Med Diss. Heidelberg, Mannheim 1995
33. Holm E, Hildebrandt W, Kinscherf R et al. Low postabsorptive net protein degradation in male cancer patients: Lack of sensitivity to regulatory amino acids? Oncol Rep 2007 17 695-700
34. Ast M, Debatin D. Splanchnischer und peripherer Substrataustausch bei metabolisch Gesunden und Karzinompatienten postabsorptiv und während parenteraler Ernährung. Med Diss. Heidelberg, Mannheim 2004
35. Tayek J A., Katz J. Glucose production, recycling, Cori cycle, and gluconeogenesis in humans: relationship to serum cortisol. Am J Physiol Endocrinol Metab 1997 272 E476-E484
36. Holroyde C P., Reichard G A. Carbohydrate metabolism in cancer cachexia. Cancer Treat Rep 1981 65 55-59 (Pubitemid 13235721)
37. Leij-Halfwerk S, Dagnelie P C., van den Berg J WO et al. Weight loss and elevated gluconeogenesis from alanine in lung cancer patients. Am J Clin Nutr 2000 71 583-589 (Pubitemid 30061240)
38. Waterhouse C, Jeanpretre N, Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res 1979 39 1968-1972 (Pubitemid 9184985)
39. Shaw J HF, Wolfe R R. Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer: The response to glucose infusion, parenteral feeding, and surgical resection. Surgery 1987 101 181-191 (Pubitemid 17026553)
40. Edn E, Edström S, Bennegard K et al. Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding. Cancer Res 1984 44 1718-1724 (Pubitemid 14125871)
41. Noguchi Y, Vydelingum N A., Brennan M F. The reversal in increased gluconeogenesis in the tumor-bearing rat by tumor removal and food intake. Surgery 1989 106 423-431 (Pubitemid 19236488)
42. Debatin D, Ast M, Tokus M et al. Hepatic gluconeogenesis (GNG) and splanchnic protein balance (SPB) in early cancer disease. Clin Nutr 2001 20 19 (Abstract)
43. Preston T, Slater C, McMillan D C. et al. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr 1998 128 1355-1360 (Pubitemid 28361429)
44. Sauer L A., Dauchy R T. Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats. Cancer Res 1983 43 3497-3503 (Pubitemid 13026596)
45. Kallinowski F, Vaupel P, Runkel S et al. Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res 1988 48 7264-7272 (Pubitemid 19014015)
46. 13C]leucine. Cancer Res 1995 55 1160-1167
47. Holm E, Hagmüller E, Staedt U et al. Substrate balances across colonic carcinomas in humans. Cancer Res 1995 55 1373-1378
48. Seyfried T N., Shelton L M. Cancer as a metabolic disease. BMC Nutr Metab 2010 7 7
49. Mazurek S, Boschek C B., Hugo F et al. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 2005 15 300-308 (Pubitemid 41058775)
50. Völker A, Tokus M, Breitkreutz R et al. Die transtumoralen Bilanzen von Glutamin, Alanin und Serin bei parenteral ernährten Patienten richten sich nach der Tumorgröe. Aktuel Ernahrungsmed 2002 27 117 (Abstract)
51. Eigenbrodt E, Kallinowski F, Ott M et al. Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Res 1998 18 3267-3274 (Pubitemid 28546445)
52. Eigenbrodt E, Gerbracht U, Mazurek S et al. Carbohydrate metabolism and neoplasia: New perspectives for diagnosis and therapy. In: Pretlow T G. Pretlow T P. eds Biochemical and Molecular Aspects of Selected Cancers. San Diego, CA Academic Press Inc 1994 311-385
53. 2 in the expansion of phosphometabolite pools found in tumor cells. Clin Rev Oncogen 1992 3 91-115
54. Kroemer G, Pouyssegur J. Tumor cell metabolism: Cancers Achilles heel. Cancer cell 2008 13 472-482 (Pubitemid 351766797)
55. Warburg O. On the origin of cancer cells. Science 1956 123 309-314
56. Sonveaux P, Vgran F, Schroeder T et al. Targeting lactate-fueled respiration seletively kills hypoxic tumor cells in mice. J Clin Invest 2008 118 3930-3942
57. Walenta S, Mueller-Klieser W F. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 2004 14 267-274 (Pubitemid 38903231)
58. Schnurr B. Metabolische Untersuchungen an Karzinompatienten. Peripherer und tumoraler Substrataustausch postabsorptiv und während Nährstoffzufuhr. Naturwiss Diss. Wien 1998
59. Sauer L A., Blask D E., Dauchy R T. Dietary factors and growth and metabolism in experimental tumors. J Nutr Biochem 2007 18 637-649 (Pubitemid 47385161)
60. Owen O E., Felig P, Morgan A P. et al. Liver and kidney metabolism during prolonged starvation. J Clin Invest 1969 48 574-583
61. Bozzetti F, Gavazzi C, Mariani L et al. Glucose-based total parenteral nutrition does not stimulate glucose uptake by human tumours. Clin Nutr 2004 23 417-421 (Pubitemid 38811680)
62. Köhl M. Konzentrationen und peripherer Austausch energieliefernder Substrate und der Aminosäuren bei Malignompatienten unter dem Einfluss zweier bilanzierter Diäten mit unterschiedlichem Fettgehalt. Med Diss. Heidelberg, Mannheim 1994
63. Coleman M D., Nickols-Richardson S M. Urinary ketones reflect serum ketone concentration but do not relate to weight loss in overweight premenopausal women following a low-carbohydrate/high-protein diet. J Am Diet Assoc 2005 105 608-611 (Pubitemid 40432395)
64. Rofe A M., Bais R, Conyers R AJ. Ketone-body metabolism in tumour-bearing rats. Biochem J 1986 233 485-491 (Pubitemid 16169497)
65. Marchut E, Guminska M, Kedryna T. The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells. Acta Biochim Pol 1986 33 7-16
66. Fine E J., Miller A, Quadros E V. et al. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Int 2009 9 14
67. Thompson J R., Wu G. The effect of ketone bodies on nitrogen metabolism in skeletal muscle. Comp Biochem Physiol B 1991 100 209-216
68. Tisdale M J., Brennan R A., Fearon K C. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer 1987 56 39-43 (Pubitemid 17097695)
69. Breitkreutz R, Tesdal K, Jentschura D et al. Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy. A randomized controlled study. Wien Klin Wochenschr 2005 117 685-692 (Pubitemid 41719684)
70. Keller U, Lustenberger M, Müller-Brand J et al. Human ketone body production and utilization studied using tracer techniques: regulation by free fatty acids, insulin, catecholamines, and thyroid hormones. Diabetes Metab Rev 1989 5 285-298 (Pubitemid 19116195)
71. Veech R L. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004 70 309-319 (Pubitemid 38200957)
72. LeRoith D, Roberts Jr C T. The insulin-like growth factor system and cancer. Cancer Lett 2003 195 127-137 (Pubitemid 36588961)
73. Gallagher E J., LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 2010 21 610-618
74. Freedland S J., Mavropoulos J, Wang A et al. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 2008 68 11-19
75. Ardawi M S., Newsholme E A. Metabolism of ketone bodies, oleate and glucose in lymphocytes of the rat. Biochem J 1984 221 255-260 (Pubitemid 14082309)
76. Garland P B., Randle P J. Control of pyruvate dehydrogenase in the perfused rat heart by the intracellular concentration of acetyl-coenzyme A. Biochem J 1964 91 6C-7C
77. van Ness van Alstyne E, Beebe S P. Diet studies in transplantable tumors. I. The effect of non-carbohydrate diet upon the growth of transplantable sarcoma in rats. J Med Res 1913 29 217-232
78. Caspari W. ber den Einfluss der Kost auf das Wachstum von Impfgeschwülsten. VI. Mitteilung. ber den Einfluss des Palmitins auf das Geschwulstwachstum. Z Krebs-forsch 1932 38 356-360
79. Otto C, Kaemmerer U, Illert B et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer 2008 8 122
80. Bravata D M., Sanders L, Huang J et al. Efficacy and safety of low-carbohydrate diets: a systematic review. J Am Med Ass 2003 289 1837-1850 (Pubitemid 37430255)
81. Brosnan J T. Comments on metabolic needs for glucose and the role of gluconeogenesis. Eur J Clin Nutr 1999 53 S107-S111 (Pubitemid 29216877)
82. Dressler A, Stöcklin B, Reithofer E et al. Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy the Austrian experience. Seizure 2010 19 404-408
83. Patel A, Pyzik P L., Turner Z et al. Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia 2010 51 1277-1282
84. Dashti H M., Mathew T C., Khadada M et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 2007 302 249-256 (Pubitemid 47202341)
85. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 1999 15 412-426 (Pubitemid 30066228)
86. Umpierrez G E., Kitabchi A E. Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol 2003 2 95-108 (Pubitemid 37055612)
87. Chen T Y., Smith W, Rosenstock J L. et al. A life-threatening complication of Atkins diet. Lancet 2006 367 958
88. Liu Y M., Williams S, Basualdo-Hammond C et al. A prospective study: growth and nutritional status of children treated with the ketogenic diet. J Am Diet Ass 2003 103 707-712 (Pubitemid 38375908)
89. Brown J K., Byers T, Doyle C, et al., American Cancer Society. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2003 53 268-291 (Pubitemid 37270571)
90. Norman H A., Butrum R R., Feldman E et al. The role of dietary supplements during cancer therapy. J Nutr 2003 133 3794S-3799S (Pubitemid 37392602)
91. Biesalski H K. Mikronährstoffsupplemente bei onkologischen Patienten. Onkologe 2008 14 45-57
92. Fletcher R H., Fairfield K M. Vitamins for chronic disease prevention in adults: clinical applications. J Am Med Ass 2002 287 3127-3129 (Pubitemid 34633988)
93. Willett W C., Stampfer M J. Clinical practice. What vitamins should I be taking, doctor? New Engl J Med 2001 345 1819-1824
94. Cantor I. Shedding light on vitamin D and integrative oncology. Integr Cancer Ther 2008 7 81-89 (Pubitemid 351806537)
95. Zhang R, Naughton D P. Vitamin D in health and disease: current perspectives. Nutr J 2010 9 65
96. Sharman M J., Kraemer W J., Love D M. et al. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr 2002 132 1879-1885 (Pubitemid 34742871)
97. Shai I, Schwarzfuchs D, Henkin Y et al, Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. New Engl J Med 2008 359 229-241 (Pubitemid 352008438)
98. Gardner C D., Kiazand A, Alhassan S et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the ATOZ Weight Loss Study: a randomized trial. J Am Med Ass 2007 297 969-977 (Pubitemid 46376751)
99. Prez-Guisado J, Muoz-Serrano A et al. Spanish Ketogenic Mediterranean Diet: a healthy cardiovascular diet for weight loss. Nutr J 2008 7 30
100. Foster G D., Wyatt H R., Hill J O. et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med 2010 153 147-157
101. Schmidt M, Pfetzer N, Schwab M et al. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metab 2011 8 54
102. McNally M A., Pyzik P L., Rubenstein J E. et al. Empiric use of potassium citrate reduces kidney-stone incidence with the ketogenic diet. Pediatrics 2009 124 e300-304
103. Sampath A, Kossoff E H., Furth S L. et al. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 2007 22 375-378 (Pubitemid 46915269)
104. Bier D M., Brosnan J T., Flatt J P. et al. Report of the IDECG Working Group on lower and upper limits of carbohydrate and fat intake. International Dietary Energy Consultative Group. Eur J Clin Nutr 1999 53 S177-S178 (Pubitemid 29216886)
105. Holm E, Schade I. Einflüsse kurzkettiger und gesättigter langkettiger Fettsäuren auf das Tumorwachstum In-vitro- und experimentelle In-vivo-Effekte. Aktuel Ernahrungsmed 2008 33 1-6